# PRD Validation and Refinement Summary - 2025-11-15

This document summarizes the activities performed during the validation and refinement of the Product Requirements Document (PRD) and Epics for the `ibe160` project.

## Initial Validation

The `validate-prd` workflow was initiated to assess the completeness and quality of the `PRD.md` and `epics.md` documents against a predefined checklist.

**Initial Findings:**

The initial validation revealed several issues, including **2 critical failures** and multiple "Failed" and "Partial" items. Key issues identified were:

*   **Critical Failures:**
    *   Epics did not explicitly cover all Functional Requirements (FR008 - data privacy was orphaned).
    *   Lack of FR traceability to stories (stories in `epics.md` did not reference FR numbers).
*   **Other Failed Items:**
    *   Missing "References" section in `PRD.md`.
    *   Lack of noted critical dependencies between FRs in `PRD.md`.
    *   No explicit reasoning for deferral of features in the "Out of Scope" section of `PRD.md`.
    *   Stories were not marked with their scope (MVP, Growth, Vision) in `epics.md`.

## Adjustments and Refinement

Based on the initial validation report, the following adjustments were made to `PRD.md` and `epics.md`:

1.  **`PRD.md` Updates:**
    *   A new "References" section was added, linking to the Product Brief and Epics document.
    *   Explicit reasoning for the deferral of each item was added to the "Out of Scope" section.
    *   A "Dependencies" subsection was added under "Functional Requirements" to note critical dependencies between FRs.

2.  **`epics.md` Updates:**
    *   A new story, "Story 1.5: Data Privacy and Security (MVP)", was added to Epic 1 to explicitly cover FR008 (data privacy) and NFR03 (GDPR compliance).
    *   FR numbers were added to the title of each story for improved traceability.
    *   All story titles were appended with "(MVP)" to clearly mark their scope.

## Re-validation Results

After implementing the adjustments, the validation workflow was re-run.

**Re-validation Findings:**

The re-validation demonstrated significant improvement, with **0 critical failures** and a high pass rate.

*   **Overall Pass Rate:** 102 out of 108 checks passed (94.44%).
*   **Critical Failures:** All critical failures were resolved.

**Remaining "Partial" Items (Areas for Further Improvement):**

While no critical issues remain, some areas were marked as "Partial" and are recommended for further improvement:

*   More explicit delineation of "Growth" and "Vision" scope in `PRD.md`.
*   Inclusion of endpoint specifications in `PRD.md` if applicable.
*   Explicit reflection of NFR01 (Performance) and NFR03 (Security/GDPR) in story acceptance criteria.
*   Provision of an explicit coverage matrix or a clear method for tracing FRs to stories.
*   Explicitly stating if performance/scale requirements are informed by research data.
*   Identification and flagging of technical unknowns.

## Conclusion

The `PRD.md` and `epics.md` documents are now in a robust state, free of critical issues, and ready to guide the subsequent phases of the project.

**Next Phase:**

The next recommended workflow is `create-design`, which is part of the "Planning" phase and is handled by the `ux-designer` agent.

**Validation Reports:**

*   Initial Validation Report: `C:\Users\birgi\SG-Oslo\docs/validation-report-2025-11-15.md`
*   Re-run Validation Report: `C:\Users\birgi\SG-Oslo\docs/validation-report-2025-11-15-rerun.md`
